Medtronic CAO exercises performance share units

Medtronic plc Chief Accounting Officer Denise L. Blomquist reported compensation-related share activity.

Rhea-AI Filing Summary

Medtronic plc Chief Accounting Officer Denise L. Blomquist reported compensation-related share activity. On May 26, 2026, she acquired 1,712 Ordinary Shares through the exercise or settlement of derivative awards. A related Performance Share Unit award covering 1,621 units converted into Ordinary Shares, leaving no remaining units from that grant. Following these transactions, she directly holds 14,974 Ordinary Shares. Footnotes state that 1,027 of the shares issued from the performance-vesting units will be delivered when her employment with Medtronic ends, underscoring that this is a structured equity award rather than an open-market trade.

Insider Trade Summary

1,621 shares exercised/converted

Exercise 2 txns

Insider Blomquist Denise L.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise	Performance Share Unit	1,621	$0.00	$0.00
Exercise	Ordinary Shares	1,712	$0.00	$0.00

Holdings After Transaction: Performance Share Unit — 0 contracts (Direct); Ordinary Shares — 14,974 shares (Direct)

Footnotes (3)

1. F1. Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends.
2. F2. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
3. F3. The performance share units vested on April 24, 2026.

Key Figures

Ordinary Shares acquired: 1,712 shares Performance Share Units converted: 1,621 units Shares held after transactions: 14,974 shares +3 more

6 metrics

Ordinary Shares acquired 1,712 shares Non-derivative transaction on May 26, 2026

Performance Share Units converted 1,621 units Derivative exercise/conversion on May 26, 2026

Shares held after transactions 14,974 shares Direct ownership following reported Form 4 activity

Deferred share delivery 1,027 shares To be delivered when employment with Medtronic ends

Exercise events 1 derivative exercise exerciseCount in transaction summary

Derivative shares exercised 1,621 shares exerciseShares in transaction summary

Key Terms

Performance Share Unit, contingent right, vested, derivative security

4 terms

Performance Share Unit financial

"Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023"

A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.

contingent right financial

"Each performance share unit represents a contingent right to receive one share of Medtronic common stock"

vested financial

"The performance share units vested on April 24, 2026"

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Medtronic (MDT) executive Denise Blomquist report in this Form 4?

Denise Blomquist reported acquiring Medtronic Ordinary Shares through equity awards. She received 1,712 Ordinary Shares tied to derivative awards and now directly holds 14,974 shares. The filing reflects compensation-related settlements, not open-market buying or selling activity.

How many Medtronic (MDT) shares does Denise Blomquist hold after the reported transactions?

After the reported transactions, Denise Blomquist directly holds 14,974 Medtronic Ordinary Shares. This total reflects the addition of 1,712 shares acquired via derivative exercise or settlement on May 26, 2026, as disclosed in the Form 4 filing.

What happened to Denise Blomquist’s Medtronic performance share units in this Form 4?

A Performance Share Unit grant covering 1,621 units was exercised or converted into Medtronic Ordinary Shares, leaving zero units from that award. Each unit represented a contingent right to receive one share, and the units had vested earlier on April 24, 2026.

Are the Medtronic (MDT) shares in this Form 4 from open-market purchases or equity awards?

The shares are from equity awards, not open-market purchases. The Form 4 describes the exercise or settlement of performance-vesting share units and derivative securities, resulting in Ordinary Shares issued as part of compensation arrangements.

What do the footnotes reveal about the Medtronic performance-vesting share units reported by Denise Blomquist?

The footnotes explain that the shares were issued upon settlement of performance-vesting share units granted July 31, 2023. Performance was certified May 26, 2026, and 1,027 of the resulting shares will be delivered when her employment with Medtronic ends.

When did Denise Blomquist’s Medtronic performance share units vest and convert to shares?

The performance share units vested on April 24, 2026. Based on performance certified on May 26, 2026, the units were settled into Medtronic Ordinary Shares, as reflected in the Form 4 transactions and accompanying footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blomquist Denise L.

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/26/2026		M		1,712(1)	A	$0	14,974	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Unit	(2)	05/26/2026		M			1,621	(3)	(3)	Ordinary Shares	1,621	$0	0	D

Explanation of Responses:

1. Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026, of which 1,027 shares will be delivered to the reporting person when her employment with the Company ends.

2. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

3. The performance share units vested on April 24, 2026.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)